Dark PoolEvent Wednesday, May 20, 2026Analyzed

Peerwise Medical, Corp.

Neutral

Summary

Peerwise Medical, Corp., a Delaware corporation incorporated in 2023, has raised $5.0M in a Regulation D private placement as of May 20, 2026. The offering is classified under 'Other Technology' and involves equity securities, with no debt or pooled investment fund interests indicated. The filing lists Natalia Khosla and Rachel O'Driscoll as executive officers and directors, but does not disclose the number of investors, whether any are non-accredited, or the minimum investment accepted. The absence of an exemption rule (506(b) or 506(c)) in the provided XML excerpt limits further structural detail, but the $5.0M raise signals early-stage capital deployment in the healthcare technology space.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Full Analysis

Executive Summary

Peerwise Medical, Corp., a Delaware corporation incorporated in 2023, has raised $5.0M in a Regulation D private placement as of May 20, 2026. The offering is classified under 'Other Technology' and involves equity securities, with no debt or pooled investment fund interests indicated. The filing lists Natalia Khosla and Rachel O'Driscoll as executive officers and directors, but does not disclose the number of investors, whether any are non-accredited, or the minimum investment accepted. The absence of an exemption rule (506(b) or 506(c)) in the provided XML excerpt limits further structural detail, but the $5.0M raise signals early-stage capital deployment in the healthcare technology space.

Investor Edge

Watch for an amended Form D (D/A) which would reveal changes in offering terms, additional investors, or a larger raise. Also monitor for any subsequent patent filings or FDA-related announcements from Peerwise Medical, as these would validate the technology and potentially attract strategic partners.

Sector capital positioning

This $5.0M raise in the 'Other Technology' sector reflects continued private capital flow into early-stage health-tech ventures, particularly those leveraging digital or platform-based models. The modest size suggests a seed or Series A round, aligning with current trends where investors are selectively backing capital-efficient startups in medical technology.

Convergence Signals

No direct convergence signals (patents, government contracts, or legislation) are evident from the filing. However, the company's New York address and incorporation in Delaware are standard for startups. The involvement of two female executives may align with broader diversity-focused investment trends, but this is speculative.

Key Takeaways

  • Peerwise Medical raised $5.0M in private equity under Regulation D, with first sale on May 20, 2026.
  • The filing lists Natalia Khosla and Rachel O'Driscoll as executive officers and directors, but no external investors are named.
  • The 'Other Technology' classification and $5.0M amount suggest an early-stage health-tech company, likely pre-revenue.

Risk Indicators & Flags

The filing lacks critical details such as the specific exemption rule (506(b) or 506(c)), total number of investors, and whether any non-accredited investors participated. This opacity could indicate a small, insider-led round or incomplete disclosure. Additionally, the company is very young (incorporated in 2023), increasing execution risk.

Verification & References

All data is directly from the SEC Form D filing (Accession Number 000213791226000001). The company's CIK (0002137912) and EDGAR URL are provided. The $5.0M raised, date of first sale (2026-05-20), and officer/director names are verifiable. The exemption rule and investor count are not available in the provided excerpt.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 26, 2026

Declaring a National Emergency to Secure the United States Bulk-Power System

This executive order declares a national emergency to restrict foreign-produced bulk-power system electric equipment that poses national security risks, prohibiting new transactions involving equipment from covered foreign entities and allowing the Secretary of Energy to impose conditions on existing equipment. It directs the Secretary of Energy, in coordination with multiple agencies, to identify, mitigate, and potentially replace risky equipment, and establishes a pre-qualification list for approved vendors.

presidential_memorandumAug 20, 2026

The National Space Transportation Policy

This memorandum directs multiple agencies to expand and modernize U.S. space launch and reentry infrastructure to support over 1,000 launches annually by 2030, expedite permitting and environmental reviews, develop new federal reentry sites, and strengthen the space transportation industrial base. It mandates range scheduling transparency, spectrum reliability, and workforce development, with specific reports and plans due within 90 to 240 days.

proclamationAug 13, 2026

Adjusting Imports of Unmanned Aircraft Systems and Unmanned Aircraft Systems Components into the United States

This proclamation imposes a 100% ad valorem tariff on imports of unmanned aircraft systems (UAS) over 25 kg, those with thermal imagers, docking stations, and certain components, and a 25% tariff on UAS under 25 kg and other components, citing national security under Section 232 of the Trade Expansion Act. It also authorizes the Department of Commerce to establish an onshoring program offering preferential tariff treatment for companies that build new U.S. manufacturing facilities for UAS and components.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →